Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome, June 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 61 articles:
HTML format


 

Single Articles

  1. RINCEL M, Olier M, Minni A, de Oliveira CM, et al
    Pharmacological restoration of gut barrier function in stressed neonates partially reverses long-term alterations associated with maternal separation.
    Psychopharmacology (Berl). 2019 May 23. pii: 10.1007/s00213-019-05252.
    Abstract    

    Abstract available

  2. MANSUETO P, Soresi M, La Blasca F, Fayer F, et al
    Body Mass Index and Associated Clinical Variables in Patients with Non-Celiac Wheat Sensitivity.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  3. BIRDER LA
    Pathophysiology of interstitial cystitis.
    Int J Urol. 2019;26 Suppl 1:12-15.
    Abstract    

    Abstract available

  4. DOAEE P, Rajaei Z, Roghani M, Alaei H, et al
    Effects of Boswellia serrata resin extract on motor dysfunction and brain oxidative stress in an experimental model of Parkinson's disease.
    Avicenna J Phytomed. 2019;9:281-290.
    Abstract    

    Abstract available

  5. ROSZKOWSKA A, Pawlicka M, Mroczek A, Balabuszek K, et al
    Non-Celiac Gluten Sensitivity: A Review.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  6. LOPES SS, Miszputen SJ, Sachs A, Lima MM, et al
    EVALUATION OF CARBOHYDRATE AND FIBER CONSUMPTION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN OUTPATIENT TREATMENT.
    Arq Gastroenterol. 2019;56:3-9.
    Abstract    

    Abstract available

  7. NOVAK T, Strait C
    A Chest X-Ray causing confusion.
    Acute Med. 2019;18:120.
    Abstract    

    Abstract available

  8. LUMLEY MA, Schubiner H
    Emotional Awareness and Expression Therapy for Chronic Pain: Rationale, Principles and Techniques, Evidence, and Critical Review.
    Curr Rheumatol Rep. 2019;21:30.
    Abstract    

    Abstract available

  9. RESNIKOFF H, Metzger JM, Lopez M, Bondarenko V, et al
    Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates.
    J Inflamm Res. 2019;12:113-126.
    Abstract    

    Abstract available

  10. GRACIE DJ, Hamlin PJ, Ford AC
    The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment.
    Lancet Gastroenterol Hepatol. 2019 May 20. pii: S2468-1253(19)30089.
    Abstract    

    Abstract available

  11. BIESIEKIERSKI JR, Jalanka J, Staudacher HM
    Can Gut Microbiota Composition Predict Response to Dietary Treatments?
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  12. BORODY TJ, Eslick GD, Clancy RL
    Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.
    Curr Opin Pharmacol. 2019;49:43-51.
    Abstract    

    Abstract available

  13. HAGERTY SL, Ellingson JM, Helmuth TB, Bidwell LC, et al
    An Overview and Proposed Research Framework for Studying Co-Occurring Mental- and Physical-Health Dysfunction.
    Perspect Psychol Sci. 2019 Jun 7:1745691619827010. doi: 10.1177/1745691619827010
    Abstract    

    Abstract available

  14. MILAJERDI A, Hassanzadeh Keshteli A, Haghighatdoost F, Azadbakht L, et al
    A direct association between dietary glycaemic index and the risk of irritable bowel syndrome-induced constipation: findings from a cross-sectional study in Iran.
    J Hum Nutr Diet. 2019 Jun 7. doi: 10.1111/jhn.12658.
    Abstract    

    Abstract available

  15. JI LJ, Li F, Zhao P, Weng LP, et al
    Silencing interleukin 1alpha underlies a novel inhibitory role of miR-181c-5p in alleviating low-grade inflammation of rats with irritable bowel syndrome.
    J Cell Biochem. 2019 Jun 6. doi: 10.1002/jcb.28794.
    Abstract    

    Abstract available


  16. In brief: Tegaserod (Zelnorm) returns.
    Med Lett Drugs Ther. 2019;61:72.
    Abstract    



  17. BLACK CJ, Yiannakou Y, Houghton LA, Ford AC, et al
    Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Clin Gastroenterol Hepatol. 2019 May 30. pii: S1542-3565(19)30587.
    Abstract    

    Abstract available

  18. PELKMANS LPJ, de Groot MJM, Curvers J
    Analytical Performance and Clinicopathologic Correlation of Four Fecal Calprotectin Methods.
    Am J Clin Pathol. 2019 Jan 6. pii: 5509899. doi: 10.1093.
    Abstract    

    Abstract available

  19. MOHAMADI J, Ghazanfari F, Drikvand FM
    Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial.
    Psychiatr Q. 2019 May 31. pii: 10.1007/s11126-019-09643.
    Abstract    

    Abstract available

  20. LAM NC, Yeung HY, Li WK, Lo HY, et al
    Cognitive Impairment in Irritable Bowel Syndrome (IBS): A systematic review.
    Brain Res. 2019 May 28. pii: S0006-8993(19)30291.
    Abstract    

    Abstract available

  21. WORTELBOER K, Nieuwdorp M, Herrema H
    Fecal microbiota transplantation beyond Clostridioides difficile infections.
    EBioMedicine. 2019 Jun 11. pii: S2352-3964(19)30375.
    Abstract    

    Abstract available

  22. NAHAR L, Paul S, Chattopadhyay A, Koley M, et al
    An open-label randomized pragmatic non-inferiority pilot trial to compare the effectiveness of Dysentery compound with individualized homeopathic medicines in irritable bowel syndrome.
    J Complement Integr Med. 2019.
    Abstract    

    Abstract available

  23. HAJIANI E, Masjedizadeh A, Shayesteh AA, Babazadeh S, et al
    Comparison between gluten-free regime and regime with gluten in symptoms of patients with irritable bowel syndrome (IBS).
    J Family Med Prim Care. 2019;8:1691-1695.
    Abstract    

    Abstract available

  24. TORKZADEH F, Danesh M, Mirbagher L, Daghaghzadeh H, et al
    Relations between Coping Skills, Symptom Severity, Psychological Symptoms, and Quality of Life in Patients with Irritable Bowel Syndrome.
    Int J Prev Med. 2019;10:72.
    Abstract    

    Abstract available

  25. NILHOLM C, Larsson E, Roth B, Gustafsson R, et al
    Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  26. CROALL ID, Trott N, Rej A, Aziz I, et al
    A Population Survey of Dietary Attitudes towards Gluten.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  27. ICENHOUR A, Labrenz F, Roderigo T, Siebert C, et al
    Are there sex differences in visceral sensitivity in young healthy men and women?
    Neurogastroenterol Motil. 2019 Jun 13:e13664. doi: 10.1111/nmo.13664.
    Abstract    

    Abstract available

  28. LIU S, Si C, Yu Y, Zhao G, et al
    Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.
    Front Cell Infect Microbiol. 2019;9:178.
    Abstract    

    Abstract available

  29. AZAMI M, Badfar G, Abangah G, Mahmoudi L, et al
    Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis.
    Gastroenterol Hepatol Bed Bench. 2019;12:85-97.
    Abstract    

    Abstract available

  30. MU Y, Cong Y
    Bacillus coagulans and its applications in medicine.
    Benef Microbes. 2019 Jun 13:1-10. doi: 10.3920/BM2018.0016.
    Abstract    

    Abstract available

  31. QI Q, Wu H, Jin X, Jin D, et al
    Effect of moxibustion on the expression of GDNF and its receptor GFRalpha3 in the colon and spinal cord of rats with irritable bowel syndrome.
    Acupunct Med. 2019 Jun 12:acupmed2017011455. doi: 10.1136/acupmed-2017-011455.
    Abstract    

    Abstract available

  32. NICHOLS RG, Peters JM, Patterson AD
    Interplay Between the Host, the Human Microbiome, and Drug Metabolism.
    Hum Genomics. 2019;13:27.
    Abstract    

    Abstract available

  33. EL-SALHY M, Gilja OH, Hatlebakk JG
    Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting.
    Mol Med Rep. 2019 May 23. doi: 10.3892/mmr.2019.10284.
    Abstract    

    Abstract available

  34. KAWANISHI H, Sekiguchi A, Funaba M, Fujii Y, et al
    Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan.
    Biopsychosoc Med. 2019;13:14.
    Abstract    

    Abstract available

  35. KETO Y, Kosako M
    [Pharmacological and clinical profile of linaclotide (Linzess((R))), a novel therapeutic agent for irritable bowel syndrome with constipation and chronic constipation].
    Nihon Yakurigaku Zasshi. 2019;153:289-298.
    Abstract    

    Abstract available

  36. KOUNTOURAS J, Gavalas E, Doulberis M, Polyzos SA, et al
    The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders.
    J Neurogastroenterol Motil. 2019 May 15. pii: jnm19033. doi: 10.5056/jnm19033.
    Abstract    



  37. YOUNG W, Carco C, Mullaney J, Maclean P, et al
    The Microbiome in Functional Gastrointestinal Disorders Is Characterized by Bacteria and Genes Involved in Carbohydrate and Bile Acid Metabolism (OR23-01-19).
    Curr Dev Nutr. 2019;3.
    Abstract    

    Abstract available

  38. ROY N, Fraser K, Young W, Cooney J, et al
    The COMFORT Cohort: Identifying Biomarkers Relevant to Functional Gastrointestinal Disorders (P20-039-19).
    Curr Dev Nutr. 2019;3.
    Abstract    

    Abstract available

  39. FRASER K, Young W, McNabb W, Gearry R, et al
    Lipid and Metabolite Profiles in Human Plasma and Associations with the Microbiome and Functional Gastrointestinal Disorders (P20-033-19).
    Curr Dev Nutr. 2019;3.
    Abstract    

    Abstract available

  40. ADAMS R, Broughton KS
    The Effect of Diet on Irritable Bowel Syndrome Symptoms and Its Role in the Treatment Plan (P12-001-19).
    Curr Dev Nutr. 2019;3.
    Abstract    

    Abstract available

  41. JAMES C, Fraser K, Young W, McNabb W, et al
    Understanding How Metabolites Link Diet, Host, and Microbiota in a Dysfunctional Gut Model Is Important to Establishing a System-wide Understanding of Gut Function (P20-035-19).
    Curr Dev Nutr. 2019;3.
    Abstract    

    Abstract available

  42. ZHANG JJ, Ma H, Zhu JZ, Lu C, et al
    The Role of Dietary Energy and Macronutrients Intake in Prevalence of Irritable Bowel Syndromes.
    Biomed Res Int. 2019;2019:8967306.
    Abstract    

    Abstract available

  43. ZHAO SS, Radner H, Siebert S, Duffield SJ, et al
    Comorbidity burden in axial spondyloarthritis: a cluster analysis.
    Rheumatology (Oxford). 2019 Apr 9. pii: 5435711.
    Abstract    

    Abstract available

  44. SOLOVYOVA G, Kvacheniuk K, Vlasyuk S, Antonyuk O, et al
    [CAPSUMEN IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME].
    Georgian Med News. 2019;:94-102.
    Abstract    

    Abstract available

  45. EK M, Roth B, Valentin L, Nordengren J, et al
    Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study.
    Eur J Obstet Gynecol Reprod Biol. 2019 Jun 15. pii: S0301-2115(19)30262.
    Abstract    

    Abstract available

  46. ZHAO J, Liao D, Gregersen H
    Mechanical analysis of intestinal contractility in a neonatal maternal deprivation irritable bowel syndrome rat model.
    J Biomech. 2019 Jun 12. pii: S0021-9290(19)30401.
    Abstract    

    Abstract available

  47. TROTT N, Aziz I, Rej A, Surendran Sanders D, et al
    How Patients with IBS Use Low FODMAP Dietary Information Provided by General Practitioners and Gastroenterologists: A Qualitative Study.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  48. SINGH P, Silvester J, Chen X, Xu H, et al
    Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    United European Gastroenterol J. 2019;7:709-715.
    Abstract    

    Abstract available

  49. ZHU SW, Liu ZJ, Sun QH, Duan LP, et al
    Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome.
    Chin Med J (Engl). 2019 Jun 12. doi: 10.1097/CM9.0000000000000306.
    Abstract    

    Abstract available

  50. COELHO A, Oliveira R, Antunes-Lopes T, Cruz CD, et al
    Partners in crime: NGF and BDNF in visceral dysfunction.
    Curr Neuropharmacol. 2019 Jun 16. pii: CN-EPUB-98832.
    Abstract    

    Abstract available

  51. STEFANO MD, Pucci E, Miceli E, Pagani E, et al
    Prevalence and pathophysiology of post-prandial migraine in patients with functional dyspepsia.
    Cephalalgia. 2019 Jun 15:333102419857596. doi: 10.1177/0333102419857596.
    Abstract    

    Abstract available

  52. MU Y, Cong Y
    Bacillus coagulans and its applications in medicine.
    Benef Microbes. 2019 Jun 17:1-10. doi: 10.3920/BM2019.0016.
    Abstract    

    Abstract available

  53. IANIRO G, Eusebi LH, Black CJ, Gasbarrini A, et al
    Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
    Aliment Pharmacol Ther. 2019 May 28. doi: 10.1111/apt.15330.
    Abstract    

    Abstract available

  54. ZAMANI M, Alizadeh-Tabari S, Zamani V
    Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome.
    Aliment Pharmacol Ther. 2019 Jun 3. doi: 10.1111/apt.15325.
    Abstract    

    Abstract available

  55. UNO Y
    Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome.
    Am J Gastroenterol. 2019 Jun 14. doi: 10.14309/ajg.0000000000000298.
    Abstract    



  56. MORALES W, Rezaie A, Barlow G, Pimentel M, et al
    Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.
    Dig Dis Sci. 2019 May 31. pii: 10.1007/s10620-019-05684.
    Abstract    

    Abstract available

  57. BAHRUDIN MF, Abdul Rani R, Tamil AM, Mokhtar NM, et al
    Effectiveness of Sterilized Symbiotic Drink Containing Lactobacillus helveticus Comparable to Probiotic Alone in Patients with Constipation-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2019 Jun 17. pii: 10.1007/s10620-019-05695.
    Abstract    

    Abstract available

  58. CHOUNG RS, Murray JA
    The Role for Food Allergies in the Pathogenesis of Irritable Bowel Syndrome: Understanding Mechanisms of Intestinal Mucosal Responses against Food Antigens.
    Gastroenterology. 2019 May 27. pii: S0016-5085(19)40923.
    Abstract    



  59. MAYER EA, Labus J, Aziz Q, Tracey I, et al
    Role of brain imaging in disorders of brain-gut interaction: a Rome Working Team Report.
    Gut. 2019 Jun 7. pii: gutjnl-2019-318308. doi: 10.1136/gutjnl-2019-318308.
    Abstract    

    Abstract available

  60. FROST F, Kacprowski T, Ruhlemann MC, Franke A, et al
    Functional abdominal pain and discomfort (IBS) is not associated with faecal microbiota composition in the general population.
    Gut. 2019;68:1131-1133.
    Abstract    



  61. MAZZAWI T, Hausken T, Hov JR, Valeur J, et al
    Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Scand J Gastroenterol. 2019 Jun 13:1-10. doi: 10.1080/00365521.2019.1624815.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;